A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System

Inclusion Criteria: * Patient or legal guardian understands procedure and provides written informed consent prior to study participation. * Patient must be able and willing to comply with all study procedures including scheduled follow-up visits and diagnostic tests. * Lesion(s) distinctly localized in the common and/or external iliac arteries. * Reference lumen diameter (RLD) 6 mm and 9 mm. * Stenosis 30% and symptomatic ischemic disease (Category 1-6 Chronic Limb Ischemia or Threatened or Irreversible Acute Limb Ischemia). Exclusion Criteria: * Patients diagnosed with preoperative coagulation disorder or with contraindications to antiplatelet or anticoagulant therapy. * Patients who are pregnant or planning to become pregnant during the clinical investigation. * Patients with a life expectancy \< 3 years. * Patients currently or scheduled to be enrolled in another investigation that conflicts with follow-up testing or may confound the study data. * Patients with absolute contraindication to x-ray contrast media or medications normally administered during an interventional procedure. * Patients with severe tortuosity or angulation of a vessel that may prevent access in the opinion of the investigator. * The presence of soft, thrombotic or embolic material within or adjacent to the lesion(s) being treated with the study device, in the opinion of the investigator.